Ilan Tsarfaty
Overview
Explore the profile of Ilan Tsarfaty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
739
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shamir I, Tsarfaty I, Paret G, Nevo-Caspi Y
Oncotarget
. 2023 Apr;
14:366-376.
PMID: 37097001
Signal transducer and activator of transcription 3 (STAT3) is a transcription factor involved in multiple fundamental biological processes and a key player in cancer development and progression. STAT3 is activated...
2.
Avlas S, Kassis H, Itan M, Reichman H, Dolitzky A, Hazut I, et al.
Front Immunol
. 2023 Apr;
14:1050245.
PMID: 37033950
Chronic inflammation is a hallmark charataristic of various inflammatory diseases including inflammatory bowel disease. Subsequently, current therapeutic approaches target immune-mediated pathways as means for therapeutic intervention and promotion of mucosal...
3.
Baranovitch O, Wolff-Bar M, Feinmesser M, Sade-Zaltz C, Tsarfaty I, Neiman V
J Integr Med
. 2021 Dec;
20(1):57-64.
PMID: 34863681
Objective: We employed a multidisciplinary approach incorporating theoretical ideas, clinical experience, psychology, physiology, traditional Chinese medicine (CM), modern practice of CM, and oncology to explore the effect of patients' repression...
4.
Shani O, Raz Y, Monteran L, Scharff Y, Levi-Galibov O, Megides O, et al.
Elife
. 2021 Jun;
10.
PMID: 34169837
Mortality from breast cancer is almost exclusively a result of tumor metastasis, and lungs are one of the main metastatic sites. Cancer-associated fibroblasts are prominent players in the microenvironment of...
5.
Hu Y, Omary M, Hu Y, Doron O, Hoermayer L, Chen Q, et al.
Nat Commun
. 2021 Mar;
12(1):1657.
PMID: 33712581
Auxin is a key regulator of plant growth and development. Local auxin biosynthesis and intercellular transport generates regional gradients in the root that are instructive for processes such as specification...
6.
Sinai-Livne T, Pasmanik-Chor M, Cohen Z, Tsarfaty I, Werner H, Berger R
Oncotarget
. 2020 May;
11(17):1515-1530.
PMID: 32391121
Clinical, epidemiological and experimental data identified the insulin-like growth factor-1 receptor (IGF1R) as a candidate therapeutic target in oncology. While this paradigm is based on well-established biological facts, including the...
7.
Kidron D, Bar-Lev Y, Tsarfaty I, Many A, Tauman R
Sleep
. 2019 Mar;
42(6).
PMID: 30903184
Study Objectives: Obstructive sleep apnea (OSA) during pregnancy has been associated with adverse maternal outcomes. However, the effect of maternal OSA on fetal growth is less clear. The placenta is...
8.
Bar-Lev Y, Moshitch-Moshkovitz S, Tsarfaty G, Kaufman D, Horev J, Resau J, et al.
PLoS One
. 2016 Jul;
11(6):e0157850.
PMID: 27359329
Objective: Metabolic dysfunctions, such as fatty liver, obesity and insulin resistance, are among the most common contemporary diseases worldwide, and their prevalence is continuously rising. Mimp/Mtch2 is a mitochondrial carrier...
9.
Huang B, Jolly M, Lu M, Tsarfaty I, Ben-Jacob E, Onuchic J
Sci Rep
. 2015 Dec;
5:17379.
PMID: 26627083
Cellular plasticity during cancer metastasis is a major clinical challenge. Two key cellular plasticity mechanisms -Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Amoeboid Transition (MAT) - have been carefully investigated individually, yet a...
10.
Hecht I, Natan S, Zaritsky A, Levine H, Tsarfaty I, Ben-Jacob E
Sci Rep
. 2015 Sep;
5:13538.
PMID: 26337223
Metastasis is the major cause for cancer patients' death, and despite all the recent advances in cancer research it is still mostly incurable. Understanding the mechanisms that are involved in...